GlassScriptPhysician profile
Supriya Ramanathan
NPI 1821099128
$1,017.60
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2022: $305 · 2023: $527 · 2024: $60.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $242.99 | 2019-2022 | |
| Biogen, INC. | $172.12 | 2022 | |
| Baxter Healthcare | $109.51 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Genzyme Corporation | $86.63 | 2023 | |
| Sobi, INC | $86.52 | 2023 | |
| Novo Nordisk INC | $64.43 | 2023 | |
| Pharming Healthcare, INC. | $55.80 | 2023-2024 | Ruconest |
| Azurity Pharmaceuticals, INC. | $37.90 | 2023 | Triptodur |
| Nestle Healthcare Nutrition INC. | $26.10 | 2023 | |
| Alcresta Therapeutics, INC. | $25.47 | 2023 | Relizorb |
| Grifols USA, LLC | $22.64 | 2023 | Xembify |
| Ascendis Pharma Endocrinology INC | $21.35 | 2023 | |
| Tolmar, INC. | $19.81 | 2023 | |
| Pfizer INC. | $17.10 | 2023 | |
| Cranial Technologies, INC | $14.76 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $14.47 | 2024 | (Ak6) Vest Therapy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Supriya Ramanathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.